Charles River Laboratories International (CRL) Operating Expenses (2009 - 2025)

Charles River Laboratories International (CRL) has reported Operating Expenses for 17 consecutive years, with $196.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Operating Expenses changed 0.22% year-over-year to $196.1 million; the TTM figure through Dec 2025 stood at $743.1 million (down 1.06% YoY), while the FY2025 annual figure was $743.1 million, down 1.06% from the prior year.
• Operating Expenses came in at $196.1 million for Q4 2025 at Charles River Laboratories International, up from $177.6 million in the prior quarter.
• The five-year high for Operating Expenses was $199.8 million in Q3 2023, with the low at $131.7 million in Q2 2022.
• Average Operating Expenses over 5 years is $176.3 million, with a median of $177.7 million recorded in 2025.
• Across the five-year window, Operating Expenses dropped 23.2% in 2022 and jumped 51.66% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $144.1 million in 2021, then surged by 38.53% to $199.6 million in 2022, then decreased by 1.25% to $197.1 million in 2023, then fell by 0.73% to $195.7 million in 2024, then gained by 0.22% to $196.1 million in 2025.
• According to Business Quant data, Operating Expenses over the past three periods registered $196.1 million, $177.6 million, and $191.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.